Farida Sohrabji

Farida Sohrabji is a Regents Professor and Department Head of Neuroscience and Experimental Therapeutics at Texas A&M University's School of Medicine. She directs the Women's Health in Neuroscience Program, advocating for sex/gender considerations in medicine. Her research focuses on neuroendocrinology, neuroinflammation, and aging-related stroke mechanisms with emphasis on female vulnerability. Key projects include gut-brain axis interactions, microRNA therapies, and translational stroke treatments. Funded by NIH institutes (NIA, NINDS, NIAAA), her work bridges basic research and clinical applications.

• Affiliations: Texas A&M College of Medicine, Women's Health in Neuroscience Program
• Education: Doctorate in Neuroscience

Research interests integrate stroke pathophysiology with sex differences, investigating how aging, hormonal status, and comorbidities influence outcomes. Recent studies highlight gut microbiome changes post-stroke and novel therapies targeting peripheral systems like IGF-1 pathways. Behavioral models assess long-term deficits like depression and cognitive impairment.

Publications emphasize sex-based disparities in stroke recovery, miRNA neuroprotection, and prenatal alcohol effects on adult health. Her grants include Cox Endowed Chair support and Woodnext Foundation funding. She trains graduate/postdoctoral scholars in translational neuroscience and gender medicine. Current lab projects explore stem cell transplants and epigenetic modifiers for stroke recovery.

Labs/Teams: Neurovascular Research Lab, Women's Health in Neuroscience Collaborative Network.